Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

BACKGROUND: To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin A supplementation and the third RTS,S/AS01 dose o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Asante, Kwaku Poku, Ansong, Daniel, Kaali, Seyram, Adjei, Samuel, Lievens, Marc, Badu, Lydia Nana, Darko, Prince Agyapong, Buabeng, Patrick Boakye Yiadom, Boahen, Owusu, Rettig, Theresa Maria, Agutu, Clara, Harrison, Samuel Benard Ekow, Ntiamoah, Yaw, Anim, Japhet Adomako, Adeniji, Elisha, Dornudo, Albert Agordo, Gvozdenovic, Emilia, Dosoo, David, Sambian, David, Owusu-Boateng, Harry, Wilson, Elvis Ato, Prempeh, Frank, Vandoolaeghe, Pascale, Schuerman, Lode, Owusu-Agyei, Seth, Agbenyega, Tsiri, Ofori-Anyinam, Opokua
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611265/
https://ncbi.nlm.nih.gov/pubmed/32192811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados